SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 30th, 2019 • Propanc Biopharma, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 30th, 2019 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of May 23, 2019, by and between PROPANC BIOPHARMA, INC., a Delaware corporation, with its address at 302, 6 Butler Street, Camberwell, VIC, 3124 Australia (the “Company”), and REDSTART HOLDINGS CORP., a New York corporation, with its address at 1188 Willis Avenue, Albertson, New York 11507 (the “Buyer”).